Skip to Content
DAEWOONG PHARMACEUTICAL CO.LTD.
About Daewoong
About Daewoong
Global Network
Company Culture
History
Ethics
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Annual Reports
Stock Info
IR
Careers
EN
KR
EN
View all menu
About Daewoong
About Daewoong
Our Purpose
CEO Message
Affiliates
Global Network
Company Culture
History
Ethics
Compliance Program
CEO Message
CP Rating
CP Activities
Contact Us
R&D
R&D Centers
R&D Projects
Achievements
Research Result
Platform Technology
Manufacturing
Capabilities
Plants
Smart Factory
FDF CDMO
Product
Biologics
Chemicals
CTD List
Newsroom
Press Release
PR Videos
Investors
Overview
Corperate Governance
Overview
Board of Directors
Stockholder Info
Stockholder's meeting
Annual Reports
Balance Sheet
Income Statement
Credit Rating
Stock Info
Stock Info
Stock Status
IR
Events & Presentations
IR Letter
Earnings announcement
Analysis Data
FAQ
Careers
Daewoong
Global Healthcare Group
The Best Partner for You
Press Release
Daewoong Pharmaceutical’s press release
NEW
1
Daewoong Pharmaceutical announced first-quarter 2022 results
2022-05
05
NEW
2
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines
2022-03
29
NEW
3
Daewoong Pharmaceutical Announces Successful Phase 3 Topline Results for New Antidiabetic Drug’s Triple Combination Therapy
2022-02
25
Daewoong Pharmaceutical announced first-quarter 2022 results
2022-05-05
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines
2022-03-29
Daewoong Pharmaceutical Announces Successful Phase 3 Topline Results for New Antidiabetic Drug’s Triple Combination Therapy
2022-02-25
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development
2022-02-21
Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug
2022-01-25
Daewoong’s “Leaps and Bounds” Q3 Performance... Exceeds KRW 20B in Operating Income for Three Consecutive Quarters
2021-11-01
Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics
2021-08-19
Daewoong, Q1 is just early stage of better performance
2021-05-06
Daewoong Pharmaceutical Signs Agreement to Export Fexuprazan, A New Drug for Gastroesophageal Reflux Disease, to China
2021-03-18
1
2
3
4
5
6
7
8
9
10
다음 페이지
Search
search word
Delete
Search